• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Curative therapies for hepatocellular carcinoma: an update and perspectives.肝细胞癌的治愈性疗法：最新进展与展望
Expert Rev Anticancer Ther. 2016;16(2):169-75. doi: 10.1586/14737140.2016.1123625. Epub 2015 Dec 14.
2
Surgical resection and liver transplantation for hepatocellular carcinoma.手术切除和肝移植治疗肝细胞癌。
Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2.
3
[Ablative techniques and the clinical utility of ablation as first-line treatment in the initial phase of hepatocellular cancer].[消融技术及消融作为肝细胞癌初始阶段一线治疗的临床应用]
Gastroenterol Hepatol. 2014 Jul;37 Suppl 2:90-4. doi: 10.1016/S0210-5705(14)70075-5.
4
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.肝切除术与经皮射频消融治疗早期肝细胞癌的成本效益比较。
J Hepatol. 2013 Aug;59(2):300-7. doi: 10.1016/j.jhep.2013.04.009. Epub 2013 Apr 18.
5
Technical Aspects of Orthotopic Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌原位肝移植的技术要点
Surg Clin North Am. 2016 Apr;96(2):269-81. doi: 10.1016/j.suc.2015.11.004. Epub 2016 Feb 16.
6
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.手术切除与射频消融治疗巴塞罗那临床肝癌分期非常早期/早期肝癌患者的生存比较。
J Hepatol. 2012 Feb;56(2):412-8. doi: 10.1016/j.jhep.2011.05.020. Epub 2011 Jul 12.
7
Liver resection for HCC outside the BCLC criteria.超出巴塞罗那临床肝癌（BCLC）标准的肝细胞癌肝切除术
Langenbecks Arch Surg. 2018 Feb;403(1):37-44. doi: 10.1007/s00423-017-1640-3. Epub 2017 Dec 4.
8
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.经皮治疗肝细胞癌：现状与创新。
J Hepatol. 2018 Apr;68(4):783-797. doi: 10.1016/j.jhep.2017.10.004. Epub 2017 Oct 13.
9
External validation of a simplified BCLC staging system for early hepatocellular carcinoma.简化 BCLC 分期系统用于早期肝细胞癌的外部验证。
Eur J Surg Oncol. 2013 Aug;39(8):850-7. doi: 10.1016/j.ejso.2013.05.001. Epub 2013 May 29.
10
Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.肝细胞癌：超越巴塞罗那临床肝癌推荐方案的外科治疗观点
World J Gastroenterol. 2014 Jun 28;20(24):7525-33. doi: 10.3748/wjg.v20.i24.7525.

引用本文的文献

1
Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells.重楼苷 I 通过下调耐药肝癌细胞中 GRP78 抑制其侵袭和转移。
Aging (Albany NY). 2023 Nov 6;15(21):12251-12263. doi: 10.18632/aging.205176.
2
Towards a tailored systemic therapy for liver cancer.迈向针对肝癌的个体化系统治疗。
Ann Transl Med. 2020 Oct;8(20):1327. doi: 10.21037/atm-20-3194.
3
Micro RNA-4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy.
微小RNA-4651在选择肝细胞癌患者进行术后辅助经动脉化疗栓塞治疗时可作为预后的潜在生物标志物。
Hepatol Commun. 2018 Sep 24;2(10):1259-1273. doi: 10.1002/hep4.1245. eCollection 2018 Oct.
4
Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma.miR-1268a 表达的预后意义及其对肝癌术后辅助经动脉化疗栓塞的有益作用。
Sci Rep. 2016 Oct 31;6:36104. doi: 10.1038/srep36104.
5
Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.用于分离肝细胞癌活循环肿瘤细胞以进行培养和药敏试验的微流控芯片
Cancer Biol Ther. 2016 Nov;17(11):1177-1187. doi: 10.1080/15384047.2016.1235665. Epub 2016 Sep 23.

肝细胞癌的治愈性疗法：最新进展与展望

Curative therapies for hepatocellular carcinoma: an update and perspectives.

作者信息

Sacco Rodolfo, Antonucci Michela, Bresci Giampaolo, Corti Ambra, Giacomelli Luca, Mismas Valeria, Rainieri Maurizio, Romano Antonio, Eggenhoffner Roberto, Tumino Emanuele, Cabibbo Giuseppe

机构信息

a Department of Gastroenterology , Pisa University Hospital , Pisa , Italy.

b Section of Radiology - Di.Bi.Me.F. , University of Palermo , Palermo , Italy.

出版信息

Expert Rev Anticancer Ther. 2016;16(2):169-75. doi: 10.1586/14737140.2016.1123625. Epub 2015 Dec 14.

DOI:10.1586/14737140.2016.1123625
PMID:26588992
Abstract

Curative treatments, including liver transplantation, surgical resection and percutaneous treatments, are the recommended therapies in BCLC-0 (Barcelona Clinic of Liver Cancer) or BCLC-A hepatocellular carcinoma (HCC). This review provides an overview of some issues of clinical importance concerning curative treatments in HCC.

摘要

根治性治疗，包括肝移植、手术切除和经皮治疗，是巴塞罗那临床肝癌（BCLC）-0期或BCLC-A期肝细胞癌（HCC）的推荐疗法。本综述概述了一些与HCC根治性治疗相关的具有临床重要性的问题。